Skip to main content

Table 2 Multivariate analyses of IM therapy failure.

From: A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line

Genes ExpB 95% CI P a P2 b
ABCB1 18.865 0.83 - 425.88 0.041  
LRPPRC 2.867E-10 1.170E-11- 7.027E-9 0.022 0.013
MCM7 6.897E9 6.897E9- 6.897E9 0.005  
  1. Abbreviation: ExpB, Exponential β; 95% CI, 95% confidence interval
  2. a p < 0.05 was considered to be significant
  3. b P2: Significance of all 3 genes together